Drug Shortage Report for SANDOZ DEFERASIROX (TYPE J)
Report ID | 155256 |
Drug Identification Number | 02489902 |
Brand name | SANDOZ DEFERASIROX (TYPE J) |
Common or Proper name | DEFERASIROX (TYPE J) |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DEFERASIROX |
Strength(s) | 180MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30FCT |
ATC code | V03AC |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2022-02-17 |
Estimated end date | 2022-02-25 |
Actual end date | 2022-02-24 |
Shortage status | Resolved |
Updated date | 2022-02-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-02-25 | English | Compare |
v5 | 2022-02-24 | French | Compare |
v4 | 2022-02-24 | English | Compare |
v3 | 2022-02-18 | English | Compare |
v2 | 2022-02-17 | French | Compare |
v1 | 2022-02-17 | English | Compare |
Showing 1 to 6 of 6